Christopher Rosicki
United States
Research Article
The Montreal Cognitive Assessment (MoCA) in Multiple Sclerosis: Relation to Clinical Features
Author(s): Leigh E. Charvet, Emily Taub, Bianca Cersosimo, Christopher Rosicki, Patricia Melville and Lauren B. KruppLeigh E. Charvet, Emily Taub, Bianca Cersosimo, Christopher Rosicki, Patricia Melville and Lauren B. Krupp
Background: The Montreal Cognitive Assessment (MoCA) is quickly becoming the most common clinical screen for cognitive impairment. Cognitive impairment is a frequent symptom of multiple sclerosis (MS) and can be difficult to detect in routine evaluation. Although specific screening measures have been studied and established for use in MS, MS cognitive screening tools may not be implemented in a general neurology setting.
Method: The present study sought to characterize the use of the Montreal Cognitive Assessment (MoCA) a brief measure employed in general neurologic practice for the detection of cognitive impairment in MS. The MoCA, along with other clinical measures, was administered to consecutively-recruited outpatients diagnosed with MS (N=259) to describe the findings and determine the frequency of detection of impairment. A subgroup (n.. Read More»
